A phase I study of tivantinib in combination with temsirolimus in patients with advanced solid tumors

Conclusions The combination of tivantinib with temsirolimus appears to be well tolerated with evidence of clinical activity.
Source: Investigational New Drugs - Category: Drugs & Pharmacology Source Type: research